Monopar Therapeutics, Inc. (MNPR)
59.27
-1.72
(-2.82%)
USD |
NASDAQ |
May 15, 16:00
59.42
+0.15
(+0.25%)
Pre-Market: 20:00
Monopar Therapeutics EPS Diluted (Quarterly) : -0.4561 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -0.3737 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
| Plus Therapeutics, Inc. | -1.03 |
| Perspective Therapeutics, Inc. | -0.2528 |
| AVITA Medical, Inc. | -0.3825 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.893M |
| Total Expenses (Quarterly) | 3.893M |
| Enterprise Value | 259.69M |
| Earnings Yield | -3.49% |
| Normalized Earnings Yield | -3.486 |